grants

New statewide initiative focuses on making the state’s next century more innovative, sustainable and equitable.

NIH-funded grants will aid interventions that improve antiretroviral medication usage.

The NIH-funded project aims to increase COVID-19 testing access and uptake for underserved and vulnerable populations.

The NIH-funded project aims to prevent infection among high-risk transgender women who face barriers to in-person interventions.

The Worker Equity Initiative will explore how government agencies and their partners help workers thrive in quality careers.

Courses will pair social justice teaching with community engagement and instruction in data literacy, statistics and computational research methods.

The project is supported by a $3.65 million grant from the Andrew W. Mellon Foundation.

The financial awards will cover research and planning for “Pacific Standard Time” projects, which will debut in 2024.

The grant comes from the National Institutes of Health to the UCLA branch of the International Maternal Pediatric Adolescent AIDS Clinical Trials Network.

Spanning medicine, math and nanomaterials, support for campus scientific studies has grown almost 40% in five years.

The new partnership will help grow startup companies based on novel aerospace technologies developed at UCLA and elsewhere.

The grant to the UCLA Center for Critical Internet Inquiry comes from the Australia-based Minderoo Foundation.

The center, funded by a $1.8 million NSF grant, will develop the fundamental chemistry needed to prepare synthetic plastics in a novel way.

Ninez Ponce and Michael Rodriguez will investigate risk factors for gun suicide and urban gun violence.

Through the institute, mathematicians work collaboratively with a broad range of scholars to address today's biggest scientific challenges.

The collaboration aims to advance the use of microbes for sustainable production of new plastics.

Researchers will work to create super-powerful computers that harness the mysterious behavior of particles at the subatomic level.

Two members of the UCLA Broad Stem Cell Research Center have received a grant for work that could be helpful in developing a vaccine.

Researchers will focus on an immunotherapy known as CAR T, which uses genetically modified stem cells to target and destroy the virus.

UCLA Fielding School of Public Health professor Marc Suchard will co-lead the effort, which has received funding from the National Institutes of Health.

The award from the National Cancer Institute will fund a series of collaborative research projects over five years at UCLA.

A team led by Andrea Bertozzi and Mason Porter will use mathematical modeling to provide insights to those developing strategies to mitigate the disease’s spread.

Participants have interned at the Metropolitan Museum of Art, the Autry Museum and the Smithsonian American Art Museum.

The NIH awarded $27.2 million to UCLA to lead the new phase of an effort to enhance diversity in the biomedical workforce.

Funds from California’s stem cell agency will support research on a blinding eye disease, cancer and an immune disorder.